Federated Hermes’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $362M | Buy |
3,008,096
+516,058
| +21% | +$59.6M | 0.59% | 40 |
|
|
2025
Q4 | $262M | Buy |
2,492,038
+2,131,343
| +591% | +$200M | 0.44% | 52 |
|
|
2025
Q3 | $30.3M | Sell |
360,695
-307,109
| -46% | -$25.3M | 0.05% | 356 |
|
|
2025
Q2 | $52.9M | Buy |
667,804
+376,312
| +129% | +$29.9M | 0.1% | 255 |
|
|
2025
Q1 | $26.2M | Sell |
291,492
-368,759
| -56% | -$34.4M | 0.06% | 350 |
|
|
2024
Q4 | $65.7M | Sell |
660,251
-235,987
| -26% | -$24.3M | 0.14% | 195 |
|
|
2024
Q3 | $102M | Sell |
896,238
-163,283
| -15% | -$19.4M | 0.22% | 111 |
|
|
2024
Q2 | $131M | Buy |
1,059,521
+36,474
| +4% | +$4.7M | 0.31% | 68 |
|
|
2024
Q1 | $135M | Buy |
1,023,047
+94,729
| +10% | +$11.7M | 0.31% | 69 |
|
|
2023
Q4 | $101M | Sell |
928,318
-10,639
| -1% | -$1.1M | 0.25% | 98 |
|
|
2023
Q3 | $96.7M | Buy |
938,957
+157,300
| +20% | +$17M | 0.26% | 86 |
|
|
2023
Q2 | $90.2M | Buy |
781,657
+116,786
| +18% | +$13.3M | 0.22% | 94 |
|
|
2023
Q1 | $70.7M | Sell |
664,871
-3,037,634
| -82% | -$328M | 0.18% | 128 |
|
|
2022
Q4 | $411M | Sell |
3,702,505
-723,032
| -16% | -$73.9M | 1.14% | 12 |
|
|
2022
Q3 | $381M | Sell |
4,425,537
-132,512
| -3% | -$11.8M | 1.12% | 7 |
|
|
2022
Q2 | $416M | Sell |
4,558,049
-951,752
| -17% | -$84.4M | 1.13% | 7 |
|
|
2022
Q1 | $452M | Sell |
5,509,801
-633,910
| -10% | -$50M | 1.02% | 10 |
|
|
2021
Q4 | $471M | Sell |
6,143,711
-1,544,339
| -20% | -$123M | 0.88% | 11 |
|
|
2021
Q3 | $623M | Buy |
7,688,050
+633,775
| +9% | +$48.2M | 1.19% | 3 |
|
|
2021
Q2 | $549M | Buy |
7,054,275
+1,256,414
| +22% | +$93.5M | 1.02% | 8 |
|
|
2021
Q1 | $426M | Buy |
5,797,861
+925,084
| +19% | +$68.2M | 0.83% | 13 |
|
|
2020
Q4 | $380M | Buy |
4,872,777
+17,143
| +0.4% | +$1.31M | 0.78% | 16 |
|
|
2020
Q3 | $384M | Buy |
4,855,634
+537,376
| +12% | +$42.1M | 0.9% | 14 |
|
|
2020
Q2 | $319M | Buy |
4,318,258
+845,384
| +24% | +$63.6M | 0.79% | 21 |
|
|
2020
Q1 | $255M | Buy |
3,472,874
+2,708,563
| +354% | +$213M | 0.75% | 22 |
|
|
2019
Q4 | $66.3M | Sell |
764,311
-33,062
| -4% | -$2.72M | 0.15% | 167 |
|
|
2019
Q3 | $64M | Sell |
797,373
-76,272
| -9% | -$6.11M | 0.16% | 149 |
|
|
2019
Q2 | $69.9M | Sell |
873,645
-823,304
| -49% | -$63M | 0.17% | 137 |
|
|
2019
Q1 | $135M | Sell |
1,696,949
-54,045
| -3% | -$4.04M | 0.33% | 58 |
|
|
2018
Q4 | $128M | Buy |
1,750,994
+152,760
| +10% | +$10.8M | 0.35% | 57 |
|
|
2018
Q3 | $108M | Buy |
1,598,234
+352,017
| +28% | +$22.4M | 0.25% | 86 |
|
|
2018
Q2 | $72.2M | Sell |
1,246,217
-5,708,298
| -82% | -$322M | 0.21% | 96 |
|
|
2018
Q1 | $361M | Sell |
6,954,515
-2,431,204
| -26% | -$131M | 1.05% | 16 |
|
|
2017
Q4 | $504M | Sell |
9,385,719
-340,557
| -4% | -$18.9M | 1.42% | 14 |
|
|
2017
Q3 | $594M | Sell |
9,726,276
-1,413,797
| -13% | -$85.7M | 1.7% | 12 |
|
|
2017
Q2 | $681M | Sell |
11,140,073
-311,160
| -3% | -$18.9M | 1.96% | 12 |
|
|
2017
Q1 | $694M | Sell |
11,451,233
-404,904
| -3% | -$24.6M | 1.98% | 10 |
|
|
2016
Q4 | $666M | Sell |
11,856,137
-5,384,904
| -31% | -$315M | 2% | 12 |
|
|
2016
Q3 | $1.03B | Buy |
17,241,041
+800,088
| +5% | +$46.8M | 2.95% | 4 |
|
|
2016
Q2 | $904M | Buy |
16,440,953
+2,458,174
| +18% | +$131M | 2.64% | 4 |
|
|
2016
Q1 | $706M | Buy |
13,982,779
+3,301,634
| +31% | +$162M | 2.19% | 8 |
|
|
2015
Q4 | $538M | Buy |
10,681,145
+51,953
| +0.5% | +$2.62M | 1.7% | 11 |
|
|
2015
Q3 | $501M | Sell |
10,629,192
-271,728
| -2% | -$14.4M | 1.62% | 11 |
|
|
2015
Q2 | $592M | Sell |
10,900,920
-68,200
| -0.6% | -$3.82M | 1.78% | 8 |
|
|
2015
Q1 | $602M | Buy |
10,969,120
+294,477
| +3% | +$16.7M | 1.83% | 8 |
|
|
2014
Q4 | $578M | Buy |
10,674,643
+46,400
| +0.4% | +$2.59M | 1.79% | 10 |
|
|
2014
Q3 | $601M | Sell |
10,628,243
-537,877
| -5% | -$30.2M | 1.93% | 6 |
|
|
2014
Q2 | $616M | Buy |
11,166,120
+567,115
| +5% | +$30.9M | 1.93% | 6 |
|
|
2014
Q1 | $574M | Sell |
10,599,005
-835,752
| -7% | -$43.3M | 1.92% | 6 |
|
|
2013
Q4 | $546M | Sell |
11,434,757
-108,261
| -0.9% | -$4.95M | 1.89% | 6 |
|
|
2013
Q3 | $524M | Sell |
11,543,018
-956,398
| -8% | -$43.7M | 2.02% | 6 |
|
|
2013
Q2 | $554M | Buy |
+12,499,416
| New | +$558M | 2.19% | 5 |
|
Other funds holding MRK
VCM
VPM
Federated Hermes's MRK Position: Q1 2026 in Review
Federated Hermes increased its Merck (MRK) stake by 21% in Q1 2026, buying an estimated $59.6M and bringing the position to 3,008,096 shares worth $362M. The position accounts for 0.59% of the portfolio, ranked #40.
Federated Hermes first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.03B in Q3 2016. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Federated Hermes held 3,008,096 shares of Merck worth $362M as of Q1 2026.
- Federated Hermes bought 516,058 Merck shares in Q1 2026, an estimated $59.6M.
- Merck made up 0.59% of Federated Hermes's portfolio in Q1 2026, its #40 holding.
- Federated Hermes first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Merck position peaked at $1.03B in Q3 2016.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.